IRON Fundamental Analysis - DISC MEDICINE INC

Fundamental Rating

Overall IRON gets a fundamental rating of 2 out of 10. We evaluated IRON against 536 industry peers in the Biotechnology industry. While IRON seems to be doing ok healthwise, there are quite some concerns on its profitability. IRON does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

IRON had negative earnings in the past year.

IRON had a negative operating cash flow in the past year.

In the past 5 years IRON always reported negative net income.

IRON had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

IRON's Return On Assets of -21.86% is fine compared to the rest of the industry. IRON outperforms 75.75% of its industry peers.

IRON has a better Return On Equity (-23.67%) than 81.90% of its industry peers.

		Industry Rank	Sector Rank
ROA	-21.86%
ROE	-23.67%
ROIC	N/A

ROA(3y)-22.05%

ROA(5y)-23.6%

ROE(3y)-24.43%

ROE(5y)-26.32%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IRON does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for IRON has been increased compared to 1 year ago.

IRON has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 28.50 indicates that IRON is not in any danger for bankruptcy at the moment.

IRON has a Altman-Z score of 28.50. This is amongst the best in the industry. IRON outperforms 93.66% of its industry peers.

IRON has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.

With a Debt to Equity ratio value of 0.05, IRON is not doing good in the industry: 60.07% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Altman-Z	28.5

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 32.11 indicates that IRON has no problem at all paying its short term obligations.

IRON has a Current ratio of 32.11. This is amongst the best in the industry. IRON outperforms 97.57% of its industry peers.

IRON has a Quick Ratio of 32.11. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.

IRON's Quick ratio of 32.11 is amongst the best of the industry. IRON outperforms 97.57% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	32.11
Quick Ratio	32.11

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for IRON have decreased strongly by -24.17% in the last year.

EPS 1Y (TTM)-24.17%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-53.4%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

IRON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.67% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-43.74%

EPS Next 2Y-26.9%

EPS Next 3Y-11.43%

EPS Next 5Y13.67%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IRON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year IRON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

IRON's earnings are expected to decrease with -11.43% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-26.9%

EPS Next 3Y-11.43%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IRON!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DISC MEDICINE INC

NASDAQ:IRON (10/9/2025, 9:20:07 PM)

After market: 70.75 0 (0%)

70.75

+0.47 (+0.67%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)08-07 2025-08-07/bmo

Earnings (Next)11-10 2025-11-10/bmo

Inst Owners89.69%

Inst Owner Change0%

Ins Owners0.45%

Ins Owner Change0.48%

Market Cap2.46B

Analysts85.56

Price Target101.72 (43.77%)

Short Float %8.11%

Short Ratio6.87

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-10.95%

Min EPS beat(2)-33.61%

Max EPS beat(2)11.71%

EPS beat(4)3

Avg EPS beat(4)2%

Min EPS beat(4)-33.61%

Max EPS beat(4)17.14%

EPS beat(8)5

Avg EPS beat(8)3.22%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0.53%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-22.63%

EPS NY rev (1m)-0.36%

EPS NY rev (3m)-20.14%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	4.01
P/tB	4.01
EV/EBITDA	N/A

EPS(TTM)-4.47

EYN/A

EPS(NY)-6.42

Fwd EYN/A

FCF(TTM)-3.9

FCFYN/A

OCF(TTM)-3.86

OCFYN/A

SpS0

BVpS17.66

TBVpS17.66

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-21.86%
ROE	-23.67%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-22.05%

ROA(5y)-23.6%

ROE(3y)-24.43%

ROE(5y)-26.32%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	1062.4%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	32.11
Quick Ratio	32.11
Altman-Z	28.5

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)193.13%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-24.17%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-53.4%

EPS Next Y-43.74%

EPS Next 2Y-26.9%

EPS Next 3Y-11.43%

EPS Next 5Y13.67%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-52.05%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-58.74%

EBIT Next 3Y-2.84%

EBIT Next 5YN/A

FCF growth 1Y-109.22%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-107.78%

OCF growth 3YN/A

OCF growth 5YN/A

DISC MEDICINE INC (IRON) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens